Back to search

Article

CD4+ T-Cells Drive Triple Negative Breast Cancer Recurrence via Non-Canonical TGFβ Signaling

2026-08-17

Abstract excerpt

Radiation therapy is a cornerstone of breast cancer treatment and reduces recurrence overall. However, patients with triple negative breast cancer (TNBC) continue to experience recurrence at higher rates than patients with other subtypes, especially when immunocompromised. While CD8⁺ T-cells are known to mitigate recurrence, the role of CD4+ T-cell subsets in shaping the irradiated microenvironment remains unclear...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39647b44-29a4-5da1-a1b9-cc2f79edd9b1
DOI
10.64898/2026.08.14.744926
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD4+ T-Cells Drive Triple Negative Breast Cancer Recurrence via Non-Canonical TGFβ SignalingDOI 10.64898/2026.08.14.744926
Select a neighboring publication to make it the new centre.